Covered, compounding — but barely income. The payout is tiny and easily covered, and growth is real — $0.26 a quarter declared Oct. 19, 2026, an 18% increase and the company's 34th consecutive annual increase — but at 0.27% the yield pays almost nothing, so this card is a compounder, not an income holding.
Key risk: A premium valuation — near a 50× trailing P/E at the Oct. 23 close — means the compounding case depends on earnings growth continuing, not on the dividend itself.
Changes if: The annual increase streak breaks, or earnings fall enough that the payout story stops being the point. The yield is already too small to carry the card alone.
- ✓Payout-coverage check: About 15% of trailing EPS of about $6.79 — $1.04 indicated against roughly $6.79 earned. Covered many times over.
- !Yield check: 0.27% indicated — $0.26/qtr × 4 at the $392.15 close on Oct. 23, 2026. Real, but negligible as income: $27 a year per $10,000 invested.
- ✓Dividend growth check: 34th consecutive annual increase, per the company's Oct. 19, 2026 declaration, which lifted the quarterly dividend 18%, from $0.22 to $0.26.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.